Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

dition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products; interpretation of clinical results; prospects for regulatory approval, including with respect to TREANDA; manufacturing development and capabilities; market prospects for its products, including with respect to AMRIX; sales, adjusted net income and basic adjusted income per common share guidance for 2007 and 2008; and other statements regarding matters that are not historical facts, including the Company's position and expected performance in 2007 and 2008, the final resolution or outcome of the ongoing investigations by the U.S. Attorney's Office and the Office of the Connecticut Attorney General and the final amount of any settlement and/or fines related thereto, and the relative strength of the foundation for the Company's ongoing compliance efforts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermo
'/>"/>
SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...wswire-FirstCall/ -- Imaging Diagnostic,Systems, ...er optical breast,imaging, announced today that a...ct to mammography is featured in the December 2008...ttp://www.newscom.com/cgi-bin/prnh/20040412/IMDSLO... at Charite Hospital in Berlin,Germany, authored...
(Date:12/4/2008)...re-FirstCall/ -- Raymond J. De Hont, Chairman and ...SE: MPR ), announced today that the Company,s Boa...008, declared a quarterly dividend of $0.06 per sh...ecord at the close of business on February 26, 200...the same period last year. , , This is the ...
(Date:12/4/2008)...Azur Pharma Limited ("Azur") today,announced that...ioSante,Pharmaceuticals, Inc ("BioSante")(Nasdaq:... Elestrin is a fast drying gel formulation of estr...erate to severe vasomotor symptoms,associated wit...d and Drug,Administration ("FDA") in December 200...
(Date:12/4/2008)... Peregrine Pharmaceutic...t will release its financial results for the secon... at 7:00 a.m. EST and will host a conference call ...ST on the same day. , , Peregrine,s senior... second quarter ended October 31, 2008 and will re...
Breaking Biology Technology:Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2Met-Pro Corporation Declares Quarterly Dividend 2Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2
... CHICAGO People are more skeptical of advertisin...greed, and the growing presence of the Internet al...eputation. The result? More power in the hands of ...ch their brandsand their backs. , ,Several present...ggested companies need to focus more on maintainin...
...he United States Court of Appeals for the Ninth C...oy Enterprises, Inc. v. Netscape Communications Co...current standard for evaluating trademark infringe... "keying," which is the practice of linking advert...ords. For instance, a person who searches a term r...
...Because a rainbow arches from its HQ all the way t...sgraced energy giant sheds its old image of ENWRON...es, the company is restructured under the new iden...o prison. The PRISMA Corporation is on a short l...s units, a big drop from the 2400 business entitie...
... Source: Fisher Paykel This past weekend, I had ...off and on, mind you, but a hard reboot. I pulled ..., then plugged this so-called state-of-the-art clo...ng lights, a trill of beeps, and voil: I was back ...nking just how complicated ordinary machines have ...
Other Biology Technology:AD:TECH: Advertisers face harsh lessons at the hands of powerful consumers 2AD:TECH: Advertisers face harsh lessons at the hands of powerful consumers 3AD:TECH: Advertisers face harsh lessons at the hands of powerful consumers 4Recent developments in the protection of trademarks on the Internet 2Recent developments in the protection of trademarks on the Internet 3Why is Enron now called Prisma? 2Why is Enron now called Prisma? 3Have you rebooted? 2Have you rebooted? 3Have you rebooted? 4
(Date:12/4/2008)...is associated with higher levels of omega-3 fatty ...ajor finding of the European study IMMIDIET that w...ican Journal of Clinical Nutriti on, an official p...nd is already available on line ( www.ajcn.org )....er alcoholic drinks. This effect could be ascribed...
(Date:12/3/2008)...wire-FirstCall/ -- BIO-key International, Inc.,(O... biometric identification,and wireless public saf...emark,Office has approved the issuance of a paten...thin a Biometric Security System" method. , ...patent (patent number,7,454,624) provide another ...
(Date:12/3/2008)...r 3, 2008. The first 5-year forest inventory repor...ilable to the public: Oregon,s Forest Resources, 2...Report. , Here are some key findings from the re... acres; about half of Oregon,s total land area of ...d to other uses particularly near urban areas. The...
(Date:12/3/2008)... 2008 -- As the United States continues to develop...y independence, cellulosic-based ethanol has emerg...gies. Corn stover remains the most popular source ...C) associated with the removal of corn fodder as a...nd environmental concern. , In the November-De...
Breaking Biology News(10 mins):A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 3BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Managing carbon loss 2Chemotherapy with gemcitabine delays progression of operable pancreatic cancer 2181 1Chemotherapy with gemcitabine delays progression of operable pancreatic cancer 2181 2Sanofi Aventis renews licenses for Genomatix chip analysis pipeline 2177 1First European IGRT School Takes Place for Radiotherapy Practitioners in UK 886 1First European IGRT School Takes Place for Radiotherapy Practitioners in UK 886 2First European IGRT School Takes Place for Radiotherapy Practitioners in UK 886 3Kaiser Permanente study 3A Alcohol amount not type wine beer liquor triggers breast cancer 2171 1Kaiser Permanente study 3A Alcohol amount not type wine beer liquor triggers breast cancer 2171 2Kaiser Permanente study 3A Alcohol amount not type wine beer liquor triggers breast cancer 2171 3
... research team led by scientists at the Broad Inst...opment of a new kind of genetic "roadmap" that can...eat them, as well as predict how new drugs work in...ew tool and its uses are described in the Septembe... in the September 28 immediate early edition of Ca...
...iabetes is a growing health problem. Giving antiox...with diabetes to control their blood sugar levels....e Milk Thistle, Silybum marianum (silymarin) is kn...blished this week in Phytotherapy Research shows t...er the amount of sugar bound to haemoglobin in blo...
...uke University engineers have shown that a three-d...uccessfully guide a surgical robot. , The scanner ..., according to the researchers. They said the scan...med without surgeons, a capability that could prov...ions. , "It,s the first time, to our knowledge, ...
... new study that takes a rare look at the physiolog...experiences in real-life settings shows that when ... they have elevated levels of cortisol shortly aft...ortisol -- a stress hormone linked to depression, ...actually cue the body on a day-to-day basis that i...
Other Biology News:Genetic 'roadmap' charts links between drugs and human disease 2Genetic 'roadmap' charts links between drugs and human disease 33-D ultrasound scanner could guide robotic surgeries 23-D ultrasound scanner could guide robotic surgeries 3Adults who go to bed lonely get stress hormone boost next morning 2Adults who go to bed lonely get stress hormone boost next morning 3
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells
These handy dispensers save space and organize gloves, safety glasses, wipers, hats, and other garb. They are the perfect benchtop storage bins for small parts used in labs, processing and manufactur
...uble staining is a technique used to reveal two di...8482;-Double Staining Kit is a Zymed polymer doubl...gens simultaneously in the same human cell or tiss... can be identified using two different primary ant...
...e FLUOstar OPTIMA is a fully automated microplate ...e labs in academia and industry. The FLUOstar inco...luorescence Intensity including FRET and multilab...ding DELFIATM High-Performance Luminescence (flas...
Biology Products: